Venus Concept Stock (NASDAQ:VERO), Trade Ideas

Venus Concept

Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.

Earnings

News

Penny Stocks

Eurozone

Commodities

Small Cap

Global

Intraday Update

Markets

Trading Ideas

ACON

AGTI

AKLI

LUNR

TRNR

VERO

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Monday.

The Dow traded down 0.08% to 39,101.76 while the NASDAQ rose 0.04% to 16,003.09. The S&amp;P 500 also fell, dropping, 0.24% to 5,076.80.

Gold Moves Lower; Pilgrim&#39;s Pride Earnings Top Views

Movers

AEHL

ATCH

BENF

BFLY

BREA

CLDX

CTCX

DHAI

DOGZ

FRPT

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IBRX

ITRI

KRYS

MARA

MIST

NBSE

NEPT

NUWE

OCGN

PSNY

ROMA

SELX

SGRY

SKYT

TBIO

TEVA

THMO

WRLD

ZJYL

ZVSA

Shares of  Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

U.S. stocks traded mixed midway through trading, with the S&amp;P 500 edging lower on Monday.

The Dow traded up 0.03% to 39,143.57 while the NASDAQ rose 0.10% to 16,013.16. The S&amp;P 500, however, fell, 0.08% to 5,084.61.

Crude Oil Gains 1%; US New Home Sales Increase In January

Venus Concept Inc

VERONI BRANDS CORP by Veroni Brands Corporation

Verona Pharma plc - American Depositary Shares

Verona Pharma PLC

Citigroup analyst Ronald Josey maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Buy and raises the price target from $168 to $190.

Price Target

Analyst Ratings

GOOG

GOOGL

Citigroup Maintains Buy on Alphabet, Raises Price Target to $190

Needham analyst Mayank Tandon maintains SS&amp;C Techs Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSNC#NASDAQ">SSNC</a>) with a Buy and raises the price target from $70 to $74.

SSNC

Needham Maintains Buy on SS&C Techs Hldgs, Raises Price Target to $74

OUTLOOK
In the&nbsp;second quarter, the company expects seasonal demand improvements across most businesses.&nbsp; Low costs for natural gas and NGLs should continue to benefit margins from LYB&#39;s North American and&nbsp;Middle East&nbsp;production relative to higher oil-based costs in most other regions.&nbsp; With the start of the summer driving season, oxyfuels and refining margins are expected to increase with higher gasoline crack spreads and lower butane costs.&nbsp; During the&nbsp;second quarter, LYB expects to operate its assets in line with market demand with average operating rates of&nbsp;85%&nbsp;for global olefins and polyolefins assets and&nbsp;80%&nbsp;for the Intermediates &amp; Derivatives assets.&nbsp; The company continues to monitor targeted stimulus efforts and remains watchful for demand improvements in&nbsp;China.

LyondellBasell For Q2 Expects Seasonal Demand Improvements Across Most Businesses

Barclays analyst Ross Sandler maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and raises the price target from $173 to $200.

Barclays Maintains Overweight on Alphabet, Raises Price Target to $200

Needham analyst Joseph Stringer reiterates Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Buy and maintains $50 price target.

Reiteration

RYTM

Needham Reiterates Buy on Rhythm Pharmaceuticals, Maintains $50 Price Target

For Nextracker, this latest expansion also marks 20 new or expanded U.S. manufacturing partner facilities since 2021 and enables the company to provide over 25 GW of U.S. solar tracker capacity each year.

Nextracker And Jennmar Holdings Subsidiary JM Steel Jointly Announced Completion Of Major Expansion Of Nextracker-dedicated Manufacturing Lines At JM Steel's Leetsdale Steel Facility Achieving 4 GW Of Capacity

The company announced that its Board of Directors has declared a quarterly dividend of&nbsp;$0.165&nbsp;per share of common stock, or&nbsp;$0.66&nbsp;per share on an annualized basis. The&nbsp;first quarter&nbsp;2024 dividend will be paid on May 14, 2024 to all stockholders of record on May 7, 2024.
In connection with the extension, the Board of Directors replenished the amount of shares authorized for repurchase under the Share Repurchase Program, resulting in available capacity of&nbsp;$50 million.

Buybacks

AROC

Archrock Reports Extension Of Share Repurchase Program For An Additional 24-Month Period

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) defied expectations this week, experiencing a price increase of around 3.7% even as investors pulled a significant amount of money out of Bitcoin <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38427873/blackrocks-spot-bitcoin-etf-sees-zero-inflows-as-net-outflows-tally-130m-on-wednesday">exchange-traded funds (ETFs)</a>.
What Happened: According to <a href="https://sosovalue.xyz/assets/etf">data</a> from SoSoValue, the total net outflow from Bitcoin spot ETFs on Thursday was a hefty $218 million. 
This outflow marks the first time that Fidelity&#8216;s (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>) and Valkyrie&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRRR#NASDAQ">BRRR</a>) ETFs witnessed net withdrawals of $22.61 million and $20.16 million, respectively. 
Grayscale&#8216;s industry-leading (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>) ETF shouldered the brunt of the outflows, experiencing a net loss of $139 million on Thursday.
Franklin Templeton&#8216;s EZBC (BATS:<a class="ticker" href="https://www.benzinga.com/stock/EZBC#BATS">EZBC</a>) was the lone bright spot, recording a modest daily net inflow of $1.87 million, while BlackRock&#8217;s iShares Bitcoin Trust (NASDAQ: <a href="https://www.benzinga.com/quote/IBIT">IBIT</a>) recorded its second straight day of no new inflows.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38441774/consensys-sues-sec-over-ethereum-classification-calls-for-regulatory-clarity">Consensys Sues SEC Over Ethereum Classification, Calls For Regulatory Clarity</a>
Despite the overall negative sentiment in the ETF market, the price of Bitcoin continues to climb, suggesting a potential disconnect between investor sentiment in the ETF market and the underlying asset itself.
This disconnect is further supported by research from JPMorgan, which indicates a weakening correlation between Bitcoin ETF prices and investor inflows, according to a Coindesk <a href="https://www.coindesk.com/markets/2024/04/26/bitcoin-stable-above-64k-while-etf-outflows-hit-200m/?utm_medium=referral&amp;utm_source=rss&amp;utm_campaign=headlines">report</a>.
While the outflows are significant, it&#8217;s worth noting that they come on the heels of a strong week for Bitcoin, with its price climbing nearly 4%. 
Additionally, liquidation data suggests a relatively stable market, with only $13.48 million worth of Bitcoin longs being liquidated in the past 24 hours.
What&#8217;s Next: The recent outflows from <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38431467/morgan-stanley-considers-broader-bitcoin-etf-sales-through-broker-network">Bitcoin spot ETFs</a> raise questions about investor sentiment and the future of this investment vehicle. Will this trend continue, or is it a temporary blip? 
What are the long-term implications for the Bitcoin market?
The Benzinga <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event, scheduled for Nov. 19, will bring together industry leaders, analysts, and investors to <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38441774/consensys-sues-sec-over-ethereum-classification-calls-for-regulatory-clarity">discuss these critical issues.</a>
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38439558/bitcoin-options-on-hold-sec-delays-decision-seeks-public-input">Bitcoin Options On Hold: SEC Delays Decision, Seeks Public Input</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

BRRR

Franklin Bitcoin ETF Franklin Bitcoin ETF

EZBC

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

Spot Bitcoin ETFs Clobbered By $218M Net Outflow On Thursday

Needham analyst Ryan MacDonald maintains Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) with a Buy and lowers the price target from $17 to $13.

ACCD

Needham Maintains Buy on Accolade, Lowers Price Target to $13

Barclays analyst Christine Cho upgrades Enphase Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>) from Equal-Weight to Overweight and announces $134 price target.

Upgrades

ENPH

Barclays Upgrades Enphase Energy to Overweight, Announces $134 Price Target

NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) reported quarterly earnings of $0.26 per share. This is a 16.13 percent decrease over earnings of $0.31 per share from the same period last year. The company reported $4.407 billion in sales this quarter. This is a 6.39 percent decrease over sales of $4.708 billion the same period last year.

NatWest Group Q1 2024 GAAP EPS $0.26 Down From $0.31 YoY, Sales $4.407B Down From $4.708B YoY

Ocugen Says It Will Present On Modifier Gene Therapy Platform At Association For Research In Vision And Ophthalmology 2024 Annual Meeting

Guidance

Barnes Raised FY24 Adjusted EPS To $1.62-$1.82 (From $1.55-$1.80) Vs. $1.70 Est.

As a result, it was determined that the Ault Global Real Estate Equities assets and liabilities previously presented as assets and liabilities held for sale within the Company's balance sheet will no longer meet the held for sale criteria. Assets of $91.0 million and liabilities of $70.4 million as of December 31, 2023 were reported as assets and liabilities held for sale. In future periods, assets and liabilities of AGREE will be reclassified to assets and liabilities held and used and amounts previously presented in discontinued operations will be reclassified into continuing operations for all periods presented.

AULT

Ault Alliance Says It Has Ended Marketing Process For Its Four Hotels Owned And Operated By Wholly Owned Subsidiary, Ault Global Real Estate Equities

JP Morgan analyst Harlan Sur maintains Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Underweight and lowers the price target from $37 to $35.

INTC

JP Morgan Maintains Underweight on Intel, Lowers Price Target to $35

For the full year of 2024, Civeo is maintaining its previously provided Adjusted EBITDA&nbsp;guidance&nbsp;range&nbsp;of&nbsp;$80 million&nbsp;to&nbsp;$90 million and capital expenditure&nbsp;guidance&nbsp;of&nbsp;$30 million&nbsp;to&nbsp;$35 million.

CVEO

Civeo Maintains FY24 Revenue Guidance Range Of $625M-$700M, Est $653.562M

Barnes Updated FY24 Guidance For Sales Growth To 13%-16% (Vs. 12%-16% Prior); Organic Sales Growth To 5%-8% (Vs. 4%-8% Prior)

LyondellBasell Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYB#NYSE">LYB</a>) reported quarterly earnings of $1.53 per share which beat the analyst consensus estimate of $1.37 by 11.68 percent. This is a 38.8 percent decrease over earnings of $2.50 per share from the same period last year. The company reported quarterly sales of $9.925 billion which beat the analyst consensus estimate of $9.730 billion by 2.00 percent. This is a 3.14 percent decrease over sales of $10.247 billion the same period last year.

Earnings Beats

LyondellBasell Industries Q1 2024 Adj EPS $1.53 Beats $1.37 Estimate, Sales $9.925B Beat $9.730B Estimate

Civeo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVEO#NYSE">CVEO</a>) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.20) by 75 percent. The company reported quarterly sales of $166.120 million which beat the analyst consensus estimate of $154.726 million by 7.36 percent. This is a 0.88 percent decrease over sales of $167.591 million the same period last year.

Earnings Misses

Civeo Q1 2024 GAAP EPS $(0.35) Misses $(0.20) Estimate, Sales $166.120M Beat $154.726M Estimate

WIIM

Exxon Mobil shares are trading lower following a Q1 earnings miss.

Venus Concept Q4 2023 Earnings Preview

Venus Concept GAAP EPS of -$2.01, revenue of $18.13M

Venus Concept Inc. (VERO) Q4 2023 Earnings Call Transcript

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Venus Concept (NASDAQ:<a href="https://investorplace.com/stock-quotes/vero-stock-quote/">VERO</a>) just reported results for the fourth quarter of 2023.<ul><li>Venus Concept reported earnings per share of -$2.01. This was below the analyst estimate for EPS of -$1.18.</li><li>The company reported revenue of $18.13 million.</li><li>This was 19.23% worse than the analyst estimate for revenue of $22.45 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/04/vero-stock-earnings-venus-concept-for-q4-of-2023/">VERO Stock Earnings: Venus Concept Misses EPS, Misses Revenue for Q4 2023</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

VERO Stock Earnings: Venus Concept Misses EPS, Misses Revenue for Q4 2023

Venus Concept (VERO) has disclosed a new risk, in the Economy & Political Environment category. Venus Concept faces increased business risk due to ...

Venus Concept's Operations Under Threat: Geopolitical Tensions in Israel Pose Risks to Business Continuity

In a report released yesterday, Marie Thibault from BTIG maintained a Hold rating on Venus Concept (VERO – Research Report). The company's shares c...

BTIG Sticks to Its Hold Rating for Venus Concept (VERO)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on High Tide (HITI – Research Report), Venus Concept ...

Analysts Offer Insights on Healthcare Companies: High Tide (HITI), Venus Concept (VERO) and Immunocore Holdings (IMCR)

Venus Concept files to sell 874,990 shares for holders

Venus Concept gets approval from Israel regulators for Venus Bliss MAX

Venus Concept files to sell 1.64M shares of common stock for holders

HITI

IMCR

Press Releases

Venus Concept Announces Closing of $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Recent Market Movers: Healthcare Companies Making Headlines: DYAI, RIGL, ARDX, VERO, MEDS

Medical Breakthrough Stocks Under $1: OCGN, VERO, RSCI, VTAK, ENVB

Health Care

General

Venus Concept Launches "NEXThetics" Program

Venus Concept Granted Continued Listing from Nasdaq Hearings Panel, Subject to Return to Compliance with Nasdaq Listing Rules

Venus Concept Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro

Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX

Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024

Financing

Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing